In the published article, there was an error in Figure 2 where parts 2A and 2C were duplicated in parts 2B and 2D. The caption should also read as “The original Kaplan-Meier PFS and OS curves from the trial and fitted curves (Weibull distributions). OS, overall survival; PFS, progression-free survival.” The corrected figure appears below.
Figure 2
(A,B) The original Kaplan-Meier PFS and OS curves from the trial and fitted curves (Weibull distributions). OS, overall survival; PFS, progression-free survival.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
programmed cell death ligand 1, avelumab, cost-effective, advanced or metastatic urothelial cancer, maintenance therapy
Citation
Xie Q, Zheng H, Chen Y and Peng X (2022) Corrigendum: Cost-effectiveness of avelumab maintenance therapy plus best supportive care vs. best supportive care alone for advanced or metastatic urothelial carcinoma. Front. Public Health 10:965798. doi: 10.3389/fpubh.2022.965798
Received
10 June 2022
Accepted
12 July 2022
Published
26 July 2022
Volume
10 - 2022
Edited and reviewed by
Mihajlo Jakovljevic, Hosei University, Japan
Updates
Copyright
© 2022 Xie, Zheng, Chen and Peng.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ye Chen huaxichenye@163.comXingchen Peng pxx2014@163.com
This article was submitted to Health Economics, a section of the journal Frontiers in Public Health
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.